25.10.2020 • News

Barentz Acquires Asian Distributor

Leading global distributor of life science ingredients Barentz has expanded its activities in the Asian life science markets with the acquisition of Singapore-headquartered Nardev, a distributor specialized in the personal care market. Financial details were not disclosed.

For the Dutch-based distributor, the purchase is a step toward strengthening its strategic position geographically. With offices and laboratories in Indonesia, Thailand, Vietnam, Malaysia and Singapore, and a broad, high-quality portfolio of personal care ingredients, Nardev’s extensive network is “fully complementary” to its own  current value position in the pertinent markets, Barentz said.

Both companies have their regional head offices in Singapore, from where Barentz also runs Vitablend, a customized formulations center.

“For us, the merger with Barentz marks the start of a new era, in which we will get more opportunities to deeper penetrate our current markets. In addition, we share with Barentz the same passion for technical knowledge and formulary support,” said Nardev’s CEO, Khoe Hong Oan.

The Asian specialty distributor employs some 90 people and has a personal care ingredients portfolio comprised of more than 3,000 products grouped into four units: Cosmetic Ingredients; Food & Nutraceuticals; Environment & Biologicals and Skin Measurement Devices.

Author: Dede Williams, Freelance Journalist

Leading global distributor of life science ingredients Barentz has expanded its...
Leading global distributor of life science ingredients Barentz has expanded its activities in the Asian life science markets with the purchase of Singapore-based Nardev, a distributor specialized in the personal care market. The portfolios are said to be fully complementary. (c) Barentz

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.